Contact
Please use this form to send email to PR contact of this press release:
Opinion/decision on a Paediatric investigation plan (PIP): Foclivia,Pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted), decision type: , therapeutic area: , PIP number: P/0188/2020
TO: